Joint Application of Multiple Inflammatory Cytokines in Diagnosis of Gout Flare

References

• Dalbeth N, Choi HK, Joosten LAB, et al. Gout. Nat Rev Dis Primers. 2019;5(1):69. doi:10.1038/s41572-019-0115-y
   PubMed Web of Science ®Google Scholar
• Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380–390. doi:10.1038/s41584-020-0441-1
   PubMed Web of Science ®Google Scholar
• Mattiuzzi C, Lippi G. Recent updates on worldwide gout epidemiology. Clin Rheumatol. 2020;39(4):1061–1063. doi:10.1007/s10067-019-04868-9
   PubMed Web of Science ®Google Scholar
• Taylor WJ, Fransen J, Jansen TL, et al. Study for updated gout classification criteria: identification of features to classify gout. Arthritis Care Res. 2015;67(9):1304–1315. doi:10.1002/acr.22585
   Google Scholar
• Narang RK, Dalbeth N. Pathophysiology of gout. Semin Nephrol. 2020;40(6):550–563. doi:10.1016/j.semnephrol.2020.12.001
   PubMedGoogle Scholar
• Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237–241. doi:10.1038/nature04516
   PubMed Web of Science ®Google Scholar
• Cronstein BN, Sunkureddi P. Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis. J Clin Rheumatol. 2013;19(1):19–29. doi:10.1097/RHU.0b013e31827d8790
   PubMedGoogle Scholar
• Scanu A, Oliviero F, Ramonda R, Frallonardo P, Dayer JM, Punzi L. Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor beta1 in the resolution phase. Ann Rheum Dis. 2012;71(4):621–624. doi:10.1136/annrheumdis-2011-200711
   PubMed Web of Science ®Google Scholar
• Bertazzo A, Punzi L, Bertazzolo N, et al. Tryptophan catabolism in synovial fluid of various arthropathies and its relationship with inflammatory cytokines. Adv Exp Med Biol. 1999;467:565–570. doi:10.1007/978-1-4615-4709-9_70
   PubMed Web of Science ®Google Scholar
• Guerne PA, Terkeltaub R, Zuraw B, Lotz M. Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum. 1989;32(11):1443–1452. doi:10.1002/anr.1780321114
   PubMed Web of Science ®Google Scholar
• McNearney T, Baethge BA, Cao S, Alam R, Lisse JR, Westlund KN. Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol. 2004;137(3):621–627. doi:10.1111/j.1365-2249.2004.02563.x
   PubMed Web of Science ®Google Scholar
• Zeng M, Dang W, Chen B, et al. IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response. Clin Rheumatol. 2016;35(9):2251–2258. doi:10.1007/s10067-015-3109-5
   PubMedGoogle Scholar
• Cavalcanti NG, Marques CD, Lins ELTU, et al. Cytokine profile in gout: inflammation driven by IL-6 and IL-18? Immunol Invest. Jul. 2016;45(5):383–395. doi:10.3109/08820139.2016.1153651
   Google Scholar
• Martin WJ, Grainger R, Harrison A, Harper JL. Differences in MSU-induced superoxide responses by neutrophils from gout subjects compared to healthy controls and a role for environmental inflammatory cytokines and hyperuricemia in neutrophil function and survival. J Rheumatol. 2010;37(6):1228–1235. doi:10.3899/jrheum.091080
   PubMedGoogle Scholar
• Horvathova V, Bohata J, Pavlikova M, et al. Interaction of the p.Q141K variant of the ABCG2 gene with clinical data and cytokine levels in primary hyperuricemia and gout. J Clin Med. 2019;8(11):65. doi:10.3390/jcm8111965
   PubMedGoogle Scholar
• Kim KW, Kim BM, Lee KA, Kim HS, Lee SH, Kim HR. Reciprocal interaction between macrophage migration inhibitory factor and interleukin-8 in gout. Clin Exp Rheumatol. 2019;37(2):270–278.
   PubMed Web of Science ®Google Scholar
• Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):1789–1798. doi:10.1136/annrheumdis-2015-208237
   PubMed Web of Science ®Google Scholar
• Dalbeth N, Stamp L. Hyperuricaemia and gout: time for a new staging system? Ann Rheum Dis. 2014;73(9):1598–1600. doi:10.1136/annrheumdis-2014-205304
   PubMed Web of Science ®Google Scholar
• Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79(5):555–562. doi:10.1038/ki.2010.462
   PubMed Web of Science ®Google Scholar
• Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2003;23(12):2131–2137. doi:10.1161/01.ATV.0000095974.95122.EC
   PubMed Web of Science ®Google Scholar
• Semple JW, Italiano JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011;11(4):264–274. doi:10.1038/nri2956
   PubMed Web of Science ®Google Scholar
• Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015;126(5):582–588. doi:10.1182/blood-2014-08-531582
   PubMed Web of Science ®Google Scholar
• Wu H, Zhou H, Chen P. Correlation of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and mean platelet volume (MPV) with gout activity: a monocentric and retrospective study. Medicine. 2022;101(35):e30242. doi:10.1097/MD.0000000000030242
   PubMed Web of Science ®Google Scholar
• Conway R, Murphy CL, Madigan A, et al. Increased platelet reactivity as measured by plasma glycoprotein VI in gout. Platelets. 2018;29(8):821–826. doi:10.1080/09537104.2017.1366974
   PubMed Web of Science ®Google Scholar
• Rhodes B, Furnrohr BG, Vyse TJ. C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol. 2011;7(5):282–289. doi:10.1038/nrrheum.2011.37
   PubMed Web of Science ®Google Scholar
• Gabay C, Lamacchia C, Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 2010;6(4):232–241. doi:10.1038/nrrheum.2010.4
   PubMed Web of Science ®Google Scholar
• Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J. 1994;8(15):1314–1325. doi:10.1096/fasebj.8.15.8001745
   PubMed Web of Science ®Google Scholar
• Jacques C, Gosset M, Berenbaum F, Gabay C. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. Vitam Horm. 2006;74:371–403. doi:10.1016/S0083-6729(06)74016-X
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87(6):2095–2147. doi:10.1182/blood.V87.6.2095.bloodjournal8762095
   PubMed Web of Science ®Google Scholar
• Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1–78. doi:10.1016/s0065-2776(08)60532-5
   PubMed Web of Science ®Google Scholar
• Zelova H, Hosek J. TNF-alpha signalling and inflammation: interactions between old acquaintances. Inflamm Res. 2013;62(7):641–651. doi:10.1007/s00011-013-0633-0
   PubMed Web of Science ®Google Scholar
• Roseff R, Wohlgethan JR, Sipe JD, Canoso JJ. The acute phase response in gout. J Rheumatol. 1987;14(5):974–977.
   PubMedGoogle Scholar
• Tang H, Zhao Y, Tan C, Liu Y. Significance of serum markers and urinary microalbumin in the diagnosis of early renal damage in patients with gout. Clin Lab. 2021;67(5):56. doi:10.7754/Clin.Lab.2020.200722
   Google Scholar
• Ma Y, Yin Z, Dai H, et al. Increased metallothionein-1 associated with gout activity and tophi. Immunol Invest. 2023:1–13. doi:10.1080/08820139.2023.2173078
   Google Scholar
• Jiang X, Li M, Yang Q, Du L, Du J, Zhou J. Oxidized low density lipoprotein and inflammation in gout patients. Cell Biochem Biophys. 2014;69(1):65–69. doi:10.1007/s12013-013-9767-5
   PubMed Web of Science ®Google Scholar
• Vitek L, Jiraskova A, Malikova I, et al. Serum bilirubin and markers of oxidative stress and inflammation in a healthy population and in patients with various forms of atherosclerosis. Antioxidants. 2022;11(11):543. doi:10.3390/antiox11112118
   Google Scholar
• Zhou ZX, Chen JK, Hong YY, et al. Relationship between the serum total bilirubin and inflammation in patients with psoriasis vulgaris. J Clin Lab Anal. 2016;30(5):768–775. doi:10.1002/jcla.21936
   PubMedGoogle Scholar
• Inoguchi T, Sonoda N, Maeda Y. Bilirubin as an important physiological modulator of oxidative stress and chronic inflammation in metabolic syndrome and diabetes: a new aspect on old molecule. Diabetol Int. 2016;7(4):338–341. doi:10.1007/s13340-016-0288-5
   PubMedGoogle Scholar
• Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20(3):895–900. doi:10.1002/art.1780200320
   PubMed Web of Science ®Google Scholar
• Janssens HJ, Fransen J, van de Lisdonk EH, van Riel PL, van Weel C, Janssen M. A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis. Arch Intern Med. 2010;170(13):1120–1126. doi:10.1001/archinternmed.2010.196
   PubMed Web of Science ®Google Scholar
• Pelaez-Ballestas I, Hernandez Cuevas C, Burgos-Vargas R, et al. Diagnosis of chronic gout: evaluating the American College of Rheumatology Proposal, European League Against Rheumatism recommendations, and clinical judgment. J Rheumatol. 2010;37(8):1743–1748. doi:10.3899/jrheum.091385
   PubMedGoogle Scholar
• Lu ZL, Chen YJ, Jing XY, Wang NN, Zhang T, Hu CJ. Detection and identification of serum peptides biomarker in papillary thyroid cancer. Med Sci Monit. 2018;24:1581–1587. doi:10.12659/msm.907768
   PubMedGoogle Scholar
• Enroth S, Berggrund M, Lycke M, et al. High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer. Commun Biol. 2019;2:221. doi:10.1038/s42003-019-0464-9
   PubMed Web of Science ®Google Scholar
• Zha X, Yang B, Xia G, Wang S. Combination of uric acid and pro-inflammatory cytokines in discriminating patients with gout from healthy controls. J Inflamm Res. 2022;15:1413–1420. doi:10.2147/JIR.S357159
   PubMed Web of Science ®Google Scholar